CD8A and carcinoma: A recent study [35] revealed that CD8+ T cells derived from normal donors are capable of recognizing TACA expressed in carcinomas and responded with high efficiency to glycopeptides in vitro, which has the potential for the design of vaccines for cancer prevention.